How should a common bile duct stone be managed in a patient without a gallbladder (post‑cholecystectomy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Common Bile Duct Stones in Post-Cholecystectomy Patients

Biliary sphincterotomy with endoscopic stone extraction via ERCP is the primary treatment for common bile duct stones in patients who have already had their gallbladder removed. 1

Primary Treatment Approach

Perform ERCP with biliary sphincterotomy and stone extraction as first-line therapy. 1 This is a strong recommendation from the British Society of Gastroenterology specifically for post-cholecystectomy patients with CBD stones, achieving success rates of approximately 90%. 2

Standard ERCP Technique

  • Begin with endoscopic sphincterotomy to dilate the papilla of Vater 3
  • Extract stones using standard basket or balloon techniques 1
  • Success rate for standard ERCP is 80-90% for stone clearance 4

Management of Large or Difficult Stones

When standard extraction fails, escalate using the following techniques in sequence:

Second-Line: Balloon Dilation

  • Add endoscopic papillary large balloon dilation (EPLBD) to sphincterotomy for large stones 1
  • This combination reduces the need for mechanical lithotripsy by 30-50% 5
  • EPLBD combined with sphincterotomy is now recommended as first-line for difficult stones (high-quality evidence) 6

Third-Line: Mechanical Lithotripsy

  • Use mechanical lithotripsy for stones >10-15mm that resist balloon dilation 2
  • This remains an effective option before proceeding to more advanced techniques 5

Fourth-Line: Cholangioscopy-Guided Lithotripsy

  • When other endoscopic options fail, use cholangioscopy-guided electrohydraulic lithotripsy (EHL) or laser lithotripsy (LL) 1
  • This achieves stone clearance rates of 73-97% in difficult cases 7
  • The European Society of Gastrointestinal Endoscopy considers this effective and safe (moderate-quality evidence) 6

Special Circumstances

Urgent Biliary Decompression

  • Patients with acute cholangitis failing antibiotics or showing septic shock require urgent ERCP within 12 hours 1
  • Place a temporary biliary stent if complete stone extraction cannot be achieved 1, 6
  • Schedule definitive stone removal within 4-6 weeks 2, 7

Coagulopathy or Difficult Anatomy

  • Consider EPBD without prior sphincterotomy using an 8mm diameter balloon 1
  • Note this increases post-ERCP pancreatitis risk but may be necessary 1

Altered Surgical Anatomy

  • For Billroth II anatomy, attempt ERCP with a forward-viewing endoscope if duodenoscope access is difficult 1
  • For Roux-en-Y gastric bypass, refer to centers offering advanced endoscopic or EUS-guided approaches 1, 7

Common Pitfalls to Avoid

Do not leave temporary biliary stents as definitive treatment. 2, 7 Stenting is only a bridge to complete stone extraction, which must occur within 4-6 weeks to prevent stent occlusion, recurrent cholangitis, and jaundice. 2

Do not perform long-term stenting instead of stone clearance unless the patient has prohibitive surgical risk or severely limited life expectancy. 7 Complete duct clearance is the standard of care and significantly reduces mortality. 7

Follow-Up After Successful Stone Removal

  • Clinical assessment at 2-4 weeks post-procedure 2
  • Verify normalization of liver function tests 2
  • Annual clinical monitoring for stone recurrence 2
  • Recurrence rates in post-cholecystectomy patients are 5.9-11.3%, significantly lower than in patients with intact gallbladders containing stones (15-23.7%) 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Follow-up Care for Patients with CBD Stenting Due to Choledocholithiasis and Cholelithiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[The Management of Common Bile Duct Stones].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2018

Research

Endoscopic management of bile duct stones.

American journal of surgery, 1989

Guideline

Management of Common Hepatic Duct Stones After Unsuccessful ERCP

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended evaluation and treatment approach for a patient with common bile duct ectasia?
What is the management approach for a patient with a benign common bile duct (CBD) stricture, possibly related to a passed stone?
What is the treatment approach for a common bile duct (CBD) stone greater than 2cm?
What is the preferred surgical approach for large impacted common bile duct (CBD) stones greater than 2cm: choledochoduodenotomy, choledochojejunostomy, or hepaticojejunostomy?
What is the cause of pain in a patient with an impacted stone in the Common Bile Duct (CBD) after a failed removal attempt, presenting with upper abdominal tenderness?
Does fibromuscular dysplasia increase the risk of stroke?
What is the appropriate workup for a patient with transaminitis (elevated alanine aminotransferase and/or aspartate aminotransferase)?
With hypertension, vasospasm, congestive heart disease, and a prior transient ischemic attack, can I take losartan and low‑dose aspirin together, and what is the optimal timing for each dose?
What are possible causes of elevated evening blood pressure in a hypertensive patient taking morning olmesartan 40 mg and evening felodipine 10 mg, with as‑needed clonidine, who has normal morning blood pressure and reports anxiety?
Is ceftriaxone (Rocephin) appropriate empiric therapy for a patient with gram‑positive cocci isolated from blood cultures?
In adolescent patients with pelvic Ewing sarcoma receiving standard multidrug chemotherapy (vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide), does neoadjuvant versus adjuvant definitive radiation affect the balance between local tumor control and severe late pelvic toxicities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.